Last updated: October 14, 2026. DEA published its revised 7-OH and mitragynine pseudoindoxyl notice in today’s Federal Register. Today’s notice is a proposal, not a temporary scheduling order. It names November 13, 2026 as the earliest date for a new order. Existing Schedule I controls on mitragynine pseudoindoxyl, MGM-15 and MGM-16 remain in effect.
What’s Happening with 7-OH?
Following an updated HHS recommendation, DEA filed a new notice on October 9 and published it on October 14, 2026. It proposes temporary Schedule I controls for 7-hydroxymitragynine (7-OH) and mitragynine pseudoindoxyl (MGPI) using concentration and ratio tests. Read the published DEA notice (DEA-1570; 91 FR 65370).
What is 7-OH?
7-OH is short for 7-hydroxymitragynine, a compound associated with the kratom plant and found in certain tablets, gummies and extract products.
The revised proposed thresholds
The new proposal would apply when either 7-OH or MGPI alone, or their combined amount when both are present, meets either test:
- Concentration: more than 1 milligram per gram (mg/g) for solids, or more than 1 milligram per milliliter (mg/mL) for liquids; OR
- Mass ratio: the mass of mitragynine divided by the mass of 7-OH, MGPI, or their combined mass when both are present, is less than 100:1.
These are proposed limits, not effective exemptions or a finding of safety. They revise the earlier July proposal; the older 0.050% and 1 mg-per-article figures should not be treated as the latest proposal. HHS explains its revised recommendation.
In today’s notice, DEA states that it is withdrawing the earlier July 7-OH notice in a separate document. This does not lift the existing August 26 controls on MGPI, MGM-15 or MGM-16. The companion notice maintains the scheduling approach for MGM-15 and MGM-16 without numerical thresholds.
When could the new controls take effect?
The published notice states that a new temporary order will be published on or after November 13, 2026. That is the earliest date under this notice, not an automatic ban date. A separate order is required and would take effect upon publication. The 30-day notice period does not itself schedule 7-OH and is not a public-comment deadline. See the published notice for timing and requirements.
What does this mean for you?
The absence of a temporary 7-OH scheduling order does not mean every 7-OH product is lawful to sell. FDA states that 7-OH is not lawful in dietary supplements or when added to conventional foods. State and local restrictions may also apply. The revised proposal does not remove the existing controls on MGPI, MGM-15 or MGM-16. Read FDA’s product guidance.
Midtown Direct Smoke Shop will comply with current laws and remove any affected products from sale when required. We will update this page as verified developments occur.
Public comment period
The earlier HHS comment period closed September 10, 2026. The revised DEA notice does not open a new public-comment period. The HHS public record and deadline extension remain available.
Additional official documents
- Existing August 26 order: MGPI, MGM-15 and MGM-16
- October 14 published companion notice: MGM-15 and MGM-16 (DEA-1644)
- FDA background and regulatory updates
Have questions?
Our team follows this closely and we’re happy to talk it through. Stop by the shop at the corner of 8th & Greenwood in Bend, or reach out through our Contact Us page.
If you or someone you care about is struggling with dependence on any substance, please see our Treatment & Recovery Resources page. No judgment — just help.
